𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pirfenidone may improve vital capacity, reduce exacerbation in IPF

Book ID
120853614
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2005
Weight
120 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[American Thoracic Society American Thor
[American Thoracic Society American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California - ()] A23. ILD: OUTCOMES AND SELECTED CLINICAL ISSUES - The CAPACITY (CAP) Trials: Randomized, Double-Blind, Placebo-Controlled, Phase III Trials of Pirfenidone (PFD) in Patients with Idiopathic Pulmonary Fibrosis (IPF).
✍ Noble, P; Albera, C; Bradford, W; Costabel, U; Kardatzke, D; King, Jr, T; Sahn, 📂 Article 📅 2009 🏛 American Thoracic Society ⚖ 153 KB